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(ROS)Abstract Osteoarthritis (OA) is the most common degenerative joint disease and a growing health
problem affecting more than half of the population over the age of 65. It is characterized by inflam-
mation in the cartilage and synovium, resulting in the loss of joint structure and progressive damage
to the cartilage. Many pro-inflammatory mediators are elevated in OA, including reactive oxygen
species (ROS) such as nitric oxide (NO) and hydrogen peroxide (H2O2). Damaged articular carti-
lage remains a challenge to treat due to the limited self-healing capacity of the tissue and unsuccess-
ful biological interventions. This highlights the need for better therapeutic strategies to heal
damaged articular cartilage. Ozone (O3) therapy has been shown to have positive results in the
treatment of OA; however the use of O3 therapy as a therapeutic agent is controversial. There is
a perception that O3 is always toxic, whereas evidence indicates that when it is applied following
a specified method, O3 can be effective in the treatment of degenerative diseases. The mechanism
of action of O3 therapy in OA is not fully understood and this review summarizes the use of O3
therapy in the treatment of damaged articular cartilage in OA.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)., South
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Osteoarthritis (OA) is the most common type of arthritis
affecting more than half of people over the age of 65 and is
more prevalent in women (18%) than in men (9.6%) after
menopause (Musumeci et al., 2015). It is a chronic, degenera-
tive joint disorder affecting millions of people worldwide
(Ashkavand et al., 2013). OA is considered as one of the most
common causes of disability affecting the joints of the knee,
hips and hands. It can be classified into two different forms
namely: primary and secondary OA. Primary or idiopathic
OA is gene dependent while secondary or post traumatic OA
occurs mainly after a traumatic event (Musumeci et al.,
2015). Although primary and secondary OA are caused by dif-
ferent factors, they both result in the same abnormalities, a
degenerative phenomenon complicated by inflammatory reac-
tions (Reynard and Loughlin, 2012). OA is a complex disease
causing a change in the tissue homeostasis of articular cartilageFigure 1 An illustration of the risk factors that are involved
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osteoarthritis. Saudi Journal of Biological Sciences (2016), http://dx.doi.org/10.1016and the subchondral bone. The common features of OA
include loss of cartilage, narrowing of joint spaces, hyper-
trophic bone changes and the formation of osteophyte
(Ashkavand et al., 2013). The latter refers to the overgrowth
of the bone and cartilage occurring at the joint margins. The
stiffening of the subchondral bone causes the bone to be less
able to absorb impact loads and thereby leading to increased
stress in the cartilage (Li and Aspden, 1997). The primary
cause of OA remains largely unknown and various factors
can play a role in the development of OA (Fig. 1). The
development of knee arthritis has been strongly associated
with excess weight, obesity, gender and previous knee injury.
Diabetes is also associated with the progression of knee OA
(Musumeci et al., 2015). The signs and symptoms of OA
usually include: pain, stiffness of the joints, muscle weakness
and swelling of the knee.
Articular cartilage is a specialized connective tissue cover-
ing the joint surfaces that has no nerve supply and is thereforein osteoarthritis (adapted from Ashkavand et al., 2013).
potential treatment modality for regeneration of damaged articular cartilage in
/j.sjbs.2016.02.002
Regeneration of damaged articular cartilage 3susceptible to early injuries (Rambani and Venkatesh, 2014). It
is a hyaline cartilage characterized by a compact collagen
network and extracellular matrix made up of proteoglycan,
and is highly resistant to mechanical loads (Sato et al.,
2014). Articular cartilage is avascular, aneural and alymphatic,
and it is constituted by one cell type, the chondrocytes. Artic-
ular cartilage has poor repair properties due to a relatively low
number of cells in the tissue, decreased metabolic rate, and
matrix fibers that restrict the division of chondrocytes and
their migration in the articular cartilage. The treatment of
injured articular cartilage poses a major challenge to orthope-
dic surgeons because of its limited self-healing capacity. To
date, there is no universally accepted successful treatment for
injured or damaged articular cartilage (Rambani and
Venkatesh, 2014).
Ozone (O3) is a colorless gas with an acrid odor and was
first discovered in 1848 (Daif, 2012). The basic function of
O3 is to protect living organisms from the harmful effects of
UV radiation. It occurs at a concentration of less than
20 lg/m3 at the earth’s surface which is a concentration that
is compatible with life (Elvis and Ekta, 2011). O3 was used
for treating gaseous post-traumatic gangrene, burns, infected
wounds and fistulas in German soldiers during World War I
(Gupta and Abhishek, 2012). Since its discovery, O3 has been
used as a therapeutic agent to treat different diseases. It exerts
its effects, by preparing the host to undergo physiopathologi-
cal events mediated by ROS (Inal et al., 2011). O3 possess both
virucidal and bactericidal properties, and can be used for dis-
infection, sterilization and destruction of malignant cells
(Eliakim et al., 2001). Hydrogen peroxide (H2O2) is produced
during O3 therapy resulting from oxidative stress and lipid oxi-
dation which mediates the biological effects of O3 therapy by
acting as second messenger (Inal et al., 2011). Repeated expo-
sure to O3 therapy may cause resistance against oxidative
stress via inducing the antioxidative system.
O3 therapy activates the enzymes that are responsible for
protecting the body against processes linked to the overpro-
duction of superoxides. During O3 therapy, there is stimula-
tion of transmembranous flow of oxygen and the induction
of enzymes such as superoxide dismutase, peroxidases or cata-
lases and the oxygen utilization in the mitochondrial respira-
tory chain becomes more effective (Madej et al., 2007).
Superoxide is the most crucial radical, playing a key role in
biological regulation (Inal et al., 2011). In the last decades a
number of orthopedics in Europe have used ozone to treat
acute and chronic knee arthritis and the results show rapid
pain relief, disappearance of edema, decongestion and
increased mobility. Unfortunately there are no experimental
studies on the mechanism of action of ozone in the knee arthri-
tis, and there is a large variability in terms of side of injection,
volume and concentration of ozone (Borrelli et al., 2015).
2. History of ozone (O3) therapy
Van Mauren, first discovered the distinctive odor of O3 in
1785. The actual gas was later discovered by a German Che-
mist Christian Friedrich Schonbein at the University of Basel
in Switzerland in 1840, when working with a voltaic pile in
the presence of oxygen (Altman, 2007). Friedrich noticed the
emergence of a gas with an electric and pungent smell, and
named it ozone, which is derived from the Greek word forPlease cite this article in press as: Manoto, S.L. et al., Medical ozone therapy as a p
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Jacques-Louis Soret, a Swiss chemist then demonstrated that
the ozone molecule was made up of three atoms of oxygen
(Altman, 2007). The disinfecting and oxidating properties of
O3 were first demonstrated in the laboratory of an Irish che-
mist, Thomas Andrews (Bocci, 2011). O3 was used for the first
time to disinfect operating rooms in a hospital in 1856, and in
1860, the first ozone water treatment plant was built in Mon-
aco to disinfect water (Altman, 2007). Werner von Siemens
practically applied the concept that O3 derives from oxygen
when an electric discharge is generated by a voltaic arc. Sie-
mens is the inventor of the super induction tube (Siemens’s
tube), consisting of two interposed electrode plates set at high
voltage, which could generate O3 in the presence of oxygen
(Bocci, 2011). An outbreak of cholera in Hamburg which
killed thirty thousand people led to the construction of the first
waterworks to use O3 in Germany in 1901 (Altman, 2007). To
date, the disinfecting properties of O3 are well known and there
are more than three thousand municipal O3 water treatment
facilities in the world (Bocci, 2011).
The first medical application of O3 was in the treatment of
post traumatic gangrene in German soldiers during the first
world war from 1914 to 1918 (Bocci, 2011). O3 was also used
to prevent infection in local medical procedures and to control
wound infections because of its prophylactic properties during
World War I (Merin et al., 2007). The invention of a reliable
O3 generator by a physicist, Joachim Hansler, was a major
breakthrough in the use of O3 for medical applications. In
the late 1980 s, there were reports that Germans were success-
fully treating HIV patients with ozonated autohemotherapy
(O3-AHT). At that time, there was no pharmacological treat-
ment of HIV, thus the Canadian government approved the
testing of O3-AHT for its safety and efficacy in treating AIDS
patients (Elvis and Ekta, 2011). O3 was effective at disinfecting
extracorporeal blood samples of HIV, but was ineffective when
applied in vivo (Elvis and Ekta, 2011).
3. Treatment of injured articular cartilage
Injured or damaged articular cartilage remains one of the most
difficult tissues to treat. There are several techniques that have
been developed in the past to treat damaged articular cartilage.
These include: arthroscopic lavage and debridement, bone
marrow stimulation technique, osteochondral autografting
(OCG), autologous chondrocyte implantation (ACI) and
now recently mesenchymal stem cells (MSCs) are used in treat-
ing injured articular cartilage.
3.1. Arthroscopic lavage and debridement
Arthroscopic lavage washes out loose cartilage, inflammatory
mediators and collagen debris that can be present in the syn-
ovium causing synovitis and effusion (Falah et al., 2010).
The debridement of cartilage (chondroplasty) aims to remove
loose chondral flaps and fibrillated articular cartilage to a
smoother surface while avoiding any damage to the healthy
surrounding cartilage (Rambani and Venkatesh, 2014).
Debridement chondroplasty can be done using several tech-
niques including curettage, and mechanical debridement with
a shaver; however this technique does not leave smooth carti-
lage and may cause further cartilage breakdown (Falah et al.,otential treatment modality for regeneration of damaged articular cartilage in
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4 S.L. Manoto et al.2010). Furthermore, thermal debridement uses radiofrequency
energy and this technique causes chondrocyte death and
matrix degeneration (Falah et al., 2010).
3.2. Bone marrow stimulation technique
This technique exposes the chondral defect to the bone mar-
row, thereby creating an environment which causes fibrocarti-
lage healing. The bone marrow stimulation technique includes
microfracture and subchondral drilling of cartilage (Rambani
and Venkatesh, 2014). The drilling technique was developed
by Pridie in 1959 in order to bring the pluripotent stem cells
into a chondral defect. The subchondral bone is drilled with
a high speed drill through the trabecular bone and blood is
allowed to perfuse into the defect resulting in the formation
of a blood clot, thereby initiating the repairing of the defect
(Falah et al., 2010). The repaired cartilage contains a mixture
of hyaline and fibrocartilage. Subchondral drilling causes ther-
mal necrosis which is a major setback of this technique. To
reduce thermal damage caused by drilling, Steadman and
Rokey, developed the microfracture technique in the late
1980 s. This technique allows the accurate debridement of all
unstable and damaged articular cartilage, down to the sub-
chondral bone plate while maintaining a stable perpendicular
edge of healthy cartilage (Smith et al., 2005). Multiple holes
in the defect are made 3–4 mm apart using an arthroscopic
awl. Following the making of a microfracture, the defect is
filled with fibrin clot, which is an optimal environment for
the pluripotential marrow cells to differentiate into stable cells
(Steadman et al., 2001). Histological analysis after a microfrac-
ture repair shows that a hybrid of hyaline and fibrocartilage
dominates the site of defect (Falah et al., 2010).
3.3. Osteochondral autografting
OCG is useful in small lesions with subchondral bone loss
(Rambani and Venkatesh, 2014). OCG involves the harvesting
of multiple individual osteochondral plugs from the donor site,
usually from a non-weight bearing area of the knee. Using a
press fit technique; the grafts from the donor site are inserted
into the lesion in a mosaic like fashion (mosaicplasty) to
replace damaged or missing articular cartilage and to supply
the chondral lesion with islands of viable and immediately
functional hyaline cartilage (Miniaci and Martineau, 2007).
This results in the formation of a surface consisting of the
transplanted hyaline cartilage and fibrocartilage from the
abrasion arthroplasty. The fibrocartilage acts a grout between
the individual grafts. The disadvantage of OCG is donor site
morbidity, but there are advantages in this being a one-step
procedure with consistent survival of the hyaline cartilage
(Rambani and Venkatesh, 2014).
3.4. Autologous chondrocyte implantation (ACI)
ACI was first conducted by Peterson and colleagues in
Gothenburg in 1987 and was the first application of cell engi-
neering in orthopedic surgery (Smith et al., 2005). In ACI, a
healthy cartilage is obtained from the affected knee and chon-
drocytes are cultured in a suitable environment (Rambani and
Venkatesh, 2014). After a few weeks, the cells are then reim-
planted into the defect underneath a patch of periosteumPlease cite this article in press as: Manoto, S.L. et al., Medical ozone therapy as a
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and this includes, characterized chondrocyte implantation
(CCI) and matrix induced ACI (MACI) which involve the
placing of cells underneath the scaffolds thereby reducing the
complications of periosteal hypertrophy seen in ACI
(Rambani and Venkatesh, 2014).
3.5. Mesenchymal stem cells (MSCs) therapy
Currently, the most innovative approach to investigate and
treat joint disorders is the use of MSCs. MSCs are multipotent
stem cells that have the ability to migrate and engraft onto
multiple musculoskeletal tissues, especially sites of injury and
undergo site specific differentiation (Chen and Tuan, 2008).
The chondrogenic differentiation potential of MSCs has made
them a hopeful candidate progenitor cell source for cartilage
tissue engineering (Qi et al., 2011). MSCs can be isolated from
many types of tissues, such as adipose tissue, bone marrow,
umbilical cord blood, placenta, synovium, periosteum and
muscle. MSCs can secrete a broad spectrum of bioactive mole-
cules with regenerative and/or immunoregulatory activities
(Caplan and Dennis, 2006). MSCs therapy allows the repairing
of both the cartilage and bone, and results in improved remod-
eling and integration with the host surface zone (Fan et al.,
2006). In general, MSCs combined with three dimensional
scaffolds and growth factors, are implanted into the cartilage
defect, and result in the repairing of the cartilage defect.
4. Reactive oxygen species (ROS) and osteoarthritis (OA)
ROS are the most abundant free radicals in the biological sys-
tem and are continuously formed as normal by products of cel-
lular metabolism (Rajendran et al., 2014). When the oxidant
level does not exceed the reducing capabilities of cells, ROS
are vital for physiological processes such as cell differentiation,
protein phosphorylation, transcription factor activation, apop-
tosis, cell immunity, steroidogenesis and cell defense against
microorganisms (Miller et al., 1993). Under normal conditions,
a delicate balance exists between free radical production and
their scavenging mechanism (Daif, 2012). In pathological con-
ditions, there is an excessive generation of ROS which can
harm cell functionality because it damages cellular lipids, pro-
teins and DNA. ROS modify proteins by the oxidation of
amino acids resulting in impaired biological activity, altered
protein structure and the accumulation of damaged proteins
in tissue (Henrotin et al., 2003). Oxidized molecules can react
with non-oxidized molecules resulting in the formation of
more oxidized molecules which may further damage the tissue
(Henrotin et al., 2003). Oxidative stress may eventually result
in cell death and the release of cellular contents into the sur-
rounding environment.
The development and progression of OA, as with other
degenerative diseases is associated with the continuous expo-
sure to oxidants (Frei, 1994). In normal physiological condi-
tions, chondrocytes live in conditions with low oxygen
supply and some of their metabolic functions require oxygen
which is supplied by the synovial fluid (Henrotin et al.,
2003). Chondrocytes thus have a metabolism adapted to
anaerobic conditions, and in response to changes in partial
oxygen pressure, mechanical stress, inflammatory and
immunomodulatory mediators, chondrocytes producepotential treatment modality for regeneration of damaged articular cartilage in
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Figure 2 An illustration of a healthy joint cushioned by articular cartilage and an osteoarthritic joint where there articular cartilage is
completely damaged and the bone ends are exposed to each other.
Regeneration of damaged articular cartilage 5increased levels of ROS (Henrotin et al., 2003). The main ROS
produced by chondrocytes are nitric oxide (NO) and superox-
ide anion (O2
) that can result in the formation of derivative
radicals such as H2O2 and peroxynitrite (ONOO
) (Hiran
et al., 1997). The ROS produced by chondrocytes can damage
the cartilage and synovial fluid by reducing its viscosity
(McCord, 1974) (Fig. 2). The production of NO is stimulated
by tumor necrosis factor (TNF)-b, interleukin (IL)-b, inter-
feron (IFN)-c and lipopolysaccharides and inhibited by IL-4,
IL-10, IL-13 and transforming growth factors (TGF)-b
(Henrotin et al., 2000; Borderie et al., 2002). Excessive produc-
tion of NO contributes to the pathogenesis of chronic arthritis
(Vailant et al., 2013). NO can also interfere with chondrocyte
function resulting in the loss of cartilage matrix by apoptosis
induction, type 2 collagen synthesis inhibition and matrix met-
alloproteinase activation (Otero et al., 2005; Musumeci et al.,
2015). Besides ROS itself, lipid peroxidation products may also
result in the formation of reactive aldehydes and lead to
inflammations (Yin et al., 2015). These lipid peroxidation
products have longer biological half-lives than free radicals
and can diffuse from the site of formation to reach a distant
target and induce cellular injury (Dwivedi et al., 2007).
5. Ozone (O3) therapy in osteoarthritis (OA)
O3 therapy has been widely used in the treatment of OA (Guo
and Zhang, 2010). The intra articular injection of O3 has been
suggested for the treatment of osteoarthritis and has yielded
positive results (Riva, 1989). Daif, 2012 showed that direct
injection of ozone into the superior joint space of patients with
internal derangement of the temporomandibular joint yielded
a good clinical outcome. The application of O3 seems to be
empirical and there are limited studies showing the histological
and biochemical evidence for the effects of its use (Iliakis et al.,
2008). O3 acts as a bioregulator by releasing factors fromPlease cite this article in press as: Manoto, S.L. et al., Medical ozone therapy as a p
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when it comes into contact with a biological fluid (Iliakis
et al., 2008). O3 can change the levels of cytokines such as
interleukin 8, TNF-a, transforming factor beta1 (TGF beta1)
and platelet derived growth factor (PDGF) (Paulesu et al.,
1991; Bocci et al., 1998). When O3 is administered intra-
venously, it dissolves in biological fluids such as plasma, urine
and lymph, where it reacts with polyunsaturated fatty acids,
antioxidants, reduced glutathione and albumin (Guven et al.,
2008). All of these compounds can act as an electron donor
and undergo oxidation. O3 causes oxidation of these com-
pounds resulting in the formation of H2O2 and lipid oxidation
products (LOPs). The following reaction shows the simultane-
ous formation of one mole of H2O2 included among ROS and
two moles of lipid oxidation products (LOPs) (Bocci, 2006).
RACH@CHAR0 þO3 þH2O! RACH@OþR0ACH@O
þH2O2
H2O2 is able to act as an ozone messenger for initiating
therapeutic and biological effects (Guven et al., 2008). Exces-
sive amounts of H2O2 can be detrimental to cells while at phys-
iological amounts H2O2 acts as a regulator of signal
transduction and is an important mediator of the host defense
and immune responses (Reth, 2002). H2O2 acts immediately
and disappears (early and short acting messengers) while LOPs
remains in the circulation and distributes throughout the tis-
sues and thus becoming late and long lasting messengers
(Bocci, 2006). This process leads to the stimulation of the
innate immune system and helps the cells to survive injury.
O3 therapy stimulates the production of interferon and inter-
leukins in the body and initiates the production of antioxidant
enzymes (Bocci, 2006). The immune system can also be stimu-
lated by activating neutrophils and stimulating the release of
cytokines. O3 increases the levels of TGFb which is important
in tissue remodeling.otential treatment modality for regeneration of damaged articular cartilage in
/j.sjbs.2016.02.002
Figure 3 Proposed mechanisms of action of ozone (O3) therapy in osteoarthritis (OA). ROS formed during OA activates NFjB
pathways by increasing its translocation into the nuclei and this causes the activation of intracellular inflammation pathways such as IL-
1b, IL-6, TNF-a and COX-2 which then open the apoptotic cascade. O3 can inhibit apoptosis and degradation of the cartilage matrix by
inhibiting the activation NFjB resulting in cell survival.
6 S.L. Manoto et al.O3 therapy reduces TNF-a concentrations, which is a
proinflammatory cytokine, activating the nuclear factor-jB
(NFjB) pathway, leading to a downstream cascade of other
proinflammatory cytokines giving rise to a vicious cycle which
perpetuates the chronic inflammatory process (Karouzakis
et al., 2006; Vailant et al., 2013). TNF-a is strongly associated
with joint and bone injury (Vailant et al., 2013). This cytokine
is also known to increase the mitochondrial ROS production
and inhibition of TNF-a may decrease ROS production in
OA, thereby causing the improvement and prevention of joint
erosion. The inhibition of TNF-a may break the noxious
NFjB pathway causing a reduction of the inflammation.
ROS can function as a second messenger to activate NFjB,
which co-ordinates the expression of a wide range of genes
involved in the inflammatory response. The efficacy of O3 ther-
apy is not only through the actions of cytokines, O3 also has
the ability to re-establish the cellular redox homeostasis
(Vailant et al., 2013). O3 can protect against overproduction
of NO and this is likely because of ozone’s action on NFjB,
since inducible nitric oxide synthase (iNOS) is regulated at
the transcriptional level by NFjB (Karouzakis et al., 2006).
It has been shown that the controlled administration of O3
may promote an oxidative preconditioning or adaptation to
oxidative stress that in turn stimulates the antioxidant endoge-
nous systems resulting in the protection against tissue damage
(Ajamieh et al., 2004). However, the exact mechanisms under-
lying preconditioning are not fully understood. NFjB is a
major regulator of inflammations in mammalian cells (Yin
et al., 2015). NFjB includes subunits such as NFjB1 (p50/
p105), NFjB2 (p52/p100), RelA (p65), RelB, c-Rel and regu-
lates inflammatory and immune responses, cell proliferationPlease cite this article in press as: Manoto, S.L. et al., Medical ozone therapy as a
osteoarthritis. Saudi Journal of Biological Sciences (2016), http://dx.doi.org/10.1016or cell death (Mitsiades et al., 2002; Hwang et al., 2012). Acti-
vation of NFjB seems to be a positive regulator of cell growth
and an inhibitor of apoptosis in fibroblasts like synoviocytes
(Yin et al., 2015). On the contrary, some studies have shown
that NFjB activation may promote apoptosis of neural cells
(Grilli et al., 1996). Inhibition of NFjB activation prevents cell
death by apoptosis in human cultured thymocytes (Bessho
et al., 1994). The functions of NFjB in whether a cell should
undergo cell proliferation or apoptosis seem to be cell type
dependent. O3 inhibition of NFjB activation may cause a
reduction in inflammation and apoptotic cell death (Fig. 3).
ROS can activate NFjB directly or through other stimuli such
as TNF-a (Chapple et al., 2013). In OA, ROS activates NFjB
pathways by increasing its translocation into the nuclei and
this causes the release of proinflammatory cytokines such as
IL-1b, IL-6, TNF-a and COX-2. These cytokines inhibit the
synthesis of aggrecan and collagen type II, which are the major
components of the cartilage matrix (Saklatvala, 1986;
Goldring et al., 1994). In addition, these cytokines increase
the release of matrix metalloproteinases and aggrecanase,
enzymes that degrade the matrices, causing cartilage damage,
disturbance of the metabolic balance of the cartilage matrix
and eventually apoptosis (Kondo et al., 2014). IL-1b and
TNF-a can induce chondrocytes apoptosis by promoting the
production of other proinflammatory factors such as prosta-
glandin E2 (PGE2) and NO (Lotz et al., 1999). O3 therapy
can block the activation of NFjB and therefore inhibiting
the release of proinflammatory cytokines. This inhibits the
degradation of the cartilage matrix and initiation of the apop-
totic pathway, thereby causing cell survival and proliferation.
O3 can stimulate the production of adenosine triphosphatepotential treatment modality for regeneration of damaged articular cartilage in
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Regeneration of damaged articular cartilage 7(ATP) through the glycolysis enzymatic pathway and increase
oxygenation to injured cells and thus prevent cell death
(Guven et al., 2008).
6. Conclusion
Once articular cartilage is damaged, it has limited potential to
repair itself. Many treatment modalities that are used to repair
damaged articular cartilage show limited efficiency. O3 therapy
is an efficient therapy in the treatment of damaged articular
cartilage in OA. O3 inhibits the inflammatory milieu which
damages the cartilage matrix and induces apoptosis of chon-
drocytes in OA. It produces its beneficial effects by normaliz-
ing the cellular redox balance and through the actions of
cytokines. Further in vitro studies are required in order to
understand the exact mechanisms involved in the stimulation
of cells by O3.
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